BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 17429875)

  • 1. Cochlear origin of early hearing loss in vestibular schwannoma.
    Gouveris HT; Victor A; Mann WJ
    Laryngoscope; 2007 Apr; 117(4):680-3. PubMed ID: 17429875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
    Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
    Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possibility for quantitative and frequency-specific assessment of auditory threshold with otoacoustic emissions].
    Dreher A; Suckfüll M; Schneeweiss S; Schorn K
    Laryngorhinootologie; 1997 Jan; 76(1):2-7. PubMed ID: 9156504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Distortion product of otoacoustic emissions in normal hearing and sensorineural hearing loss].
    Schlögel H; Stephan K; Böheim K; Welzl-Müller K
    HNO; 1995 Jan; 43(1):19-24. PubMed ID: 7890546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of cochlear function with distortion products of otoacoustic emissions in acoustic neuroma].
    Oeken J
    HNO; 1996 Dec; 44(12):677-84. PubMed ID: 9081952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
    Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
    Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of the early auditory effects of hyperlipoproteinemia and diabetes mellitus using otoacoustic emissions.
    Erdem T; Ozturan O; Miman MC; Ozturk C; Karatas E
    Eur Arch Otorhinolaryngol; 2003 Feb; 260(2):62-6. PubMed ID: 12582780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochlear function in facioscapulohumeral muscular dystrophy.
    Balatsouras DG; Korres S; Manta P; Panousopoulou A; Vassilopoulos D
    Otol Neurotol; 2007 Jan; 28(1):7-10. PubMed ID: 17106430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased amplitudes of distortion product otoacoustic emissions in patients with unilateral acoustic neuroma.
    Gouveris H; Mann W
    ORL J Otorhinolaryngol Relat Spec; 2004; 66(6):302-5. PubMed ID: 15668528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose.
    Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K
    Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient evoked otoacoustic emissions and contralateral suppressions in children with auditory listening problems.
    Yalçinkaya F; Yilmaz ST; Muluk NB
    Auris Nasus Larynx; 2010 Feb; 37(1):47-54. PubMed ID: 19411150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion product otoacoustic emissions in an industrial setting.
    Korres GS; Balatsouras DG; Tzagaroulakis A; Kandiloros D; Ferekidou E; Korres S
    Noise Health; 2009; 11(43):103-10. PubMed ID: 19414930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing threshold estimation using concurrent measurement of distortion product otoacoustic emissions and auditory steady-state responses.
    Rosner T; Kandzia F; Oswald JA; Janssen T
    J Acoust Soc Am; 2011 Feb; 129(2):840-51. PubMed ID: 21361442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cochlear neuromas.
    Leonetti JP
    Am J Otol; 1998 Jul; 19(4):499-502. PubMed ID: 9661762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Applying distortion product otoacoustic emission in testing human sensory hearing loss].
    Chen X; Zheng H; Zheng Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):382-4. PubMed ID: 15181843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.